Internal Medicine Alert – October 15, 2006
October 15, 2006
View Issues
-
The Estrogen Controversy: It's Not Just for Women
A total of 2084 men from two Framingham Heart Study cohorts had endogenous levels of total serum estrogen, testosterone and dehydroepiandrosterone sulfate (DHEA-S) measured. -
How Low Can You Go?
For hypertensives with coronary artery disease, lowering the diastolic pressure below 70-80 mm Hg appears to create increased risk of morbidity and mortality from myocardial infarction and all-cause death. -
Who Follows Breast Cancer Screening Guidelines?
A retrospective review of patient records representing preventive healthcare visits of women aged 50-69 revealed that gynecologists are more likely than family physicians or internists to follow breast cancer screening guidelines. -
Impulse Control Disorders in Parkinson's Disease: Too Much of a Good Thing?
Treatment of Parkinson's disease with dopamine agonist medications may precipitate impulse-control disorders such as compulsive gambling, buying, and hypersexuality. -
Idursulfase Solution for Intravenous Infusion (Elaprase)
The FDA has approved the first product for the treatment of Hunter syndrome. Idursulfase is a purified form of iduronate-2-sulfase, a 525-amino acid glycoprotein, produced by recombinant DNA technology. -
Clinical Briefs By Louis Kuritzky, MD
Other than water, tea is the most often consumed beverage in the world. Animal studies and in vitro data support the potential role of green tea consumption (GTC) for reducing cardiovascular disease and cancer. -
ECG Review: Early Repolarization with Artifact
The ECG image used in this article was obtained from a previously healthy, middle-aged man with some atypical but new-onset chest discomfort. -
Pharmacology Watch
A team from UCSF recently reviewed company documents that were entered into the public record as a result of litigation over the promotion of gabapentin (Neurontin) between 1994 and 1998.